In vivo, Ex-4 has been demonstrated to inhibit prostate cancer cell growth by activating GLP-1R, reducing s-phase kinase-associated protein-2 (SKP2) gene expression, subsequently increasing p27Kip1 (p27) protein levels, and inducing tumor cell cycle arrest [67]
Retatrutide drives the caloric deficit through profound appetite suppression and increased energy expenditure
(You can search the NIHR 'Be Part of Research' website, but always discuss eligibility with your clinician) What are the established treatment options that might better address my symptoms
Patients who experience intolerable side effects at any dose can remain at their current level longer before titrating upward
The right question is not shot or pill? The right question is: which medication is safe, effective, affordable, tolerable, and realistic for this patient to stay on
Retatrutide's 6-day half-life means it takes 4-5 weeks to reach steady-state levels at each dose, which is why the standard protocol uses gradual 4-week escalation intervals